Government Context

Documents Documents by topic Documents by agency Pricing Log in Create account

Login Create account

Nonrulemaking

Levoxyl (levothyroxine sodium) tablets (NDA #21-301)-CLOSED

🏛 Food and Drug Administration (FDA)FDA-2003-P-0363

Documents

5

Total comments

0

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

📄 Primary document

OtherNov 18, 2003

Petition Denial from FDA Associate Commissioner for Policy and Planning to Hogan & Hartson, LLP

No comment period

Other· Jun 20, 2003
Letter from FDA DMB to Hogan & Hartson, L.L.P→
No comment period
Other· Jun 20, 2003
Unsigned Letter from FDA DMB to Hogan & Hartson, L.L.P→
No comment period
Other· May 7, 2003
Petition Approval from FDA CDER to Mylan Pharmaceuticals, Inc.→
No comment period
Other· Mar 21, 2003
Acknowledgment Letter from FDA DMB to Mylan Pharmaceuticals Inc.→
No comment period